trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline:: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist

被引：52

作者：

Cueva, Juan Pablo ^{[1
]}

Giorgioni, Gianfabio ^{[1
]}

Grubbs, Russell A. ^{[1
]}

Chemel, Benjamin R. ^{[1
]}

Watts, Val J. ^{[1
]}

Nichols, David E. ^{[1
]}

机构：

[1] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 23期

关键词：

D O I：

10.1021/jm0604979

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report the synthesis of trans-2,3-dihydroxy-6a, 7,8,12b-tetrahydro-6H-chromeno[ 3,4-c] isoquinoline hydrochloride 6 and the resolution of its enantiomers. This new compound is an oxygen bioisostere of the potent dopamine D-1-selective full agonist dihydrexidine. The initial synthetic approach involved, as a key step, a Suzuki coupling between a chromene triflate and a boronate ester, followed by isoquinoline formation and reduction of the resulting isoquinoline. Subsequently, a more efficient route was developed that involved conjugate addition of an aryl Grignard reagent to a 2-nitrochromene. The title compound possessed high affinity ( K-i = 20-30 nM) for porcine D-1-like receptors in native striatal tissue and full intrinsic activity at cloned human dopamine D-1 receptors but had much lower affinity at dopamine D-2-like receptors ( K-i = 3000 nM). The binding and functional properties of this compound illustrate again the utility of constructing dopamine D-1 agonist ligands around the beta-phenyldopamine pharmacophore template.

引用

页码：6848 / 6857

页数：10

共 34 条

[21]

Pal K, 1995, SYNTHESIS-STUTTGART, P1485

[22] Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands [J].